Are Drug Companies Grooming New Customers in the Womb?


From The Baltimore Sun: Over time, studies have shown that antidepressants during pregnancy are linked with congenital defects as well as increased incidence of depression in offspring. In March, GlaxoSmithKline agreed to pay $6.2 million to settle a class action lawsuit on behalf of children born with congenital heart and lung defects due to their mothers’ use of Paxil while pregnant.

Article →­

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time